Coverage
-
May 28, 2014
Boehringer Ingelheim International GmbH has agreed to pay roughly $650 million to settle claims in multidistrict litigation that its blood thinner Pradaxa caused serious injuries including severe bleeding, the German drugmaker said Wednesday.
6 other articles on this case.
View all »